SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-229829
Filing Date
2014-06-09
Accepted
2014-06-09 11:51:01
Documents
6
Period of Report
2014-06-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d740878d8k.htm 8-K 27449
2 EX-2.1 d740878dex21.htm EX-2.1 363677
3 EX-99.1 d740878dex991.htm EX-99.1 54257
4 EX-99.2 d740878dex992.htm EX-99.2 22685
5 GRAPHIC g740878g15o42.jpg GRAPHIC 7851
6 GRAPHIC g740878g61x22.jpg GRAPHIC 3436
  Complete submission text file 0001193125-14-229829.txt   485136
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

IRS No.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-49839 | Film No.: 14898551
SIC: 2834 Pharmaceutical Preparations